How Does Fructose Intake Contribute to Obesity?

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -
  • More than 40% of adults in the United States have obesity, of whom almost 10% have severe obesity.
  • Obesity is a risk factor for many health conditions, including cardiovascular diseases, type 2 diabetes, and some cancers.
  • The fundamental cause of obesity is an energy imbalance between calories consumed and calories expended.
  • However, it may not be just the amount of calories, but the source of those calories that can lead to obesity. 
  • New research suggests that fructose — a simple sugar found in many foods — may drive obesity and related health conditions.

According to the World Health Organization (WHO)Trusted Source, some 13% of adults worldwide have obesity. Although obesity rates are increasing in low-income countries, most are in higher-income countries.

Follow the link below to read the full article on Medical News Today

https://www.medicalnewstoday.com/articles/how-does-fructose-intake-contribute-to-obesity?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-08-07&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -